Table 1 Presentation characteristics
From: IPM chemotherapy in cytokine refractory renal cell cancer
Number of patients | 33 | |
Metastatic at diagnosis | 14 out of 33 | |
Radical nephrectomy | 21 out of 33 | (inc. two with PA nodes) |
Median interval radical surgery to commencing cytokines (in those 21 patients) | 31.4 months | (1.6–92.8) |
Male : female | 29 : 4 | |
Median age | 51 | (27–70) |
Hb | ||
<12 | 22 | |
>12 | 11 | |
WBC | ||
<10 | 23 | |
>10 | 10 | |
Platelets | ||
<450 | 22 | |
>450 | 11 | |
LDH | ||
<480 | 19 | |
>480 | 14 | |
PS | ||
0 | 5 | |
1 | 16 | |
2 | 8 | |
3 | 4 | |
No. metastatic sites | ||
1 | 12 | |
2 | 14 | |
3 | 7 | |
Median duration of disease | 23.6 months | (3.1–162.4) |
<2 years | 16 | |
>2 years | 17 | |
Median duration of metastases | 15.6 months | (0.2–80.3) |
<1 year | 13 | |
>1 year | 20 |